Results 321 to 330 of about 194,026 (392)
The Efficacy of Potassium-Competitive Acid Blocker Compared With Double Dose of Proton Pump Inhibitor in Patients With Refractory Gastro-Esophageal Reflux Disease: A Case-Control Study. [PDF]
Lim NR, Chung WC.
europepmc +1 more source
A defect‐engineered triad catalyst (DMOF‐SNP‐siRNA) has been developed to enhance mild photothermal therapy for cancer treatment by addressing the limitations of heat shock protein overexpression and suboptimal therapeutic outcomes. This synergy induces potent apoptotic and ferroptotic responses, significantly enhancing the photothermal and catalytic ...
Fanghua Zhang +9 more
wiley +1 more source
Proton Pump Inhibitor Use and Risk of Clostridioides difficile Infection: An Umbrella Review of 11 Meta-Analyses. [PDF]
Nalabothula S +4 more
europepmc +1 more source
This article introduces a biomimetic Mn‐doped polydopamine nanoplatform (HAMM NPs) coated with cancer cell membranes. It enables targeted hepatocellular carcinoma theranostics via T1/T2 dual‐mode magnetic resonance imaging and tumor microenvironment‐triggered sonodynamic therapy/chemodynamic therapy, achieving potent antitumor efficacy in subcutaneous ...
Jiayin Lin +7 more
wiley +1 more source
Pre-hospital proton pump inhibitor use and clinical outcomes in hospitalized COVID-19 patients: A retrospective case-control study. [PDF]
Shanmugavel Geetha H +9 more
europepmc +1 more source
In this study, the synthesis and detailed photophysical characterization of SiNcs functionalized with structurally diverse axial ligands designed to enhance solubility and evaluate photophysical properties are reported. The lead compound, SiNc 3‐PP, demonstrates photothermal conversion efficiency of 62.1% and pronounced photoacoustic contrast at 810 nm,
Pedro M. R. Santos +11 more
wiley +1 more source
Association Between Long-Term Proton Pump Inhibitor Therapy and Vitamin B12 Status: A Systematic Review and Meta-Analysis. [PDF]
Parnham O, Patient W.
europepmc +1 more source

